Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
andrea.tubaro@uniroma1.it
Andrea Tubaro
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
E-mail:
andrea.tubaro@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Urinary incontinence in multiple sclerosis: Prevalence, severity and impact on patients' quality of life
EUROPEAN JOURNAL OF NEUROLOGY
2016
Detrusor overactivity increases bladder wall thickness in male patients: a urodynamic multicenter cohort study
NEUROUROLOGY AND URODYNAMICS
2016
Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines. Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study
UROLOGY
2016
Inflammatory mediators in the development and progression of benign prostatic hyperplasia
NATURE REVIEWS. UROLOGY
2016
The impact of central obesity on storage luts and urinary incontinence after prostatic surgery
CURRENT UROLOGY REPORTS
2016
Combination therapies for improved management of lower urinary tract symptoms/benign prostatic hyperplasia
DRUGS OF TODAY
2016
Tamsulosin or silodosin adjuvant treatment is ineffective in improving shockwave lithotripsy outcome. A short-term follow-up randomized, placebo-controlled study
JOURNAL OF ENDOUROLOGY
2016
Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer. An Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study
BJU INTERNATIONAL
2016
Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter Corona database
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
2016
Metabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk. Results from a multicenter biopsy study
BMC CANCER
2016
Lower urinary tract symptoms and metabolic disorders. ICI-RS 2014
NEUROUROLOGY AND URODYNAMICS
2016
Bladder wall thickness in women with symptoms of overactive bladder and detrusor overactivity. Results from the randomised, placebo-controlled shrink study
NEUROUROLOGY AND URODYNAMICS
2016
Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy. Results from a multicentre prospective study
BMC CANCER
2016
A multicenter randomized noninferiority trial comparing greenlight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction. two-yr outcomes of the GOLIATH study
EUROPEAN UROLOGY
2016
Grey Zone: Urinary Incontinence
EUROPEAN UROLOGY FOCUS
2016
MP35-11 METABOLIC ABNORMALITIES LINKED TO AN INCREASED CARDIOVASCULAR RISK ARE ASSOCIATED WITH HIGHER STORAGE LOWER URINARY TRACT SYMPTOMS
THE JOURNAL OF UROLOGY
2016
The diagnosis of benign prostatic obstruction. Development of a clinical nomogram
NEUROUROLOGY AND URODYNAMICS
2016
The evolving picture of lower urinary tract symptom management
EUROPEAN UROLOGY
2015
TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in vivo
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
2015
Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
EUROPEAN UROLOGY
2015
« prima
< precedente
1
2
3
4
5
6
7
8
9
10
11
12
seguente ›
ultima »
Progetti di Ricerca
Effetti della combinazione sequenziale di Mitomicina e Bacillo di Calmette e Guérin rispetto alla monoterapia con Bacillo di Calmette e Guérin nel trattamento del carcinoma uroteliale non muscolo invasivo di alto grado con alto rischio di progressione
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma